Alps Advisors Inc. Raises Stock Position in Amdocs Limited (NASDAQ:DOX)

Alps Advisors Inc. boosted its position in shares of Amdocs Limited (NASDAQ:DOX - Free Report) by 7.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 214,630 shares of the technology company's stock after buying an additional 15,430 shares during the period. Alps Advisors Inc. owned 0.19% of Amdocs worth $19,639,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the company. OneDigital Investment Advisors LLC increased its holdings in Amdocs by 20.8% in the first quarter. OneDigital Investment Advisors LLC now owns 3,026 shares of the technology company's stock valued at $277,000 after buying an additional 521 shares during the last quarter. Farther Finance Advisors LLC boosted its stake in Amdocs by 17.5% in the first quarter. Farther Finance Advisors LLC now owns 988 shares of the technology company's stock valued at $90,000 after acquiring an additional 147 shares in the last quarter. Cambridge Investment Research Advisors Inc. boosted its stake in Amdocs by 7.8% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 6,738 shares of the technology company's stock valued at $616,000 after acquiring an additional 490 shares in the last quarter. HighTower Advisors LLC boosted its stake in Amdocs by 20.0% in the fourth quarter. HighTower Advisors LLC now owns 15,374 shares of the technology company's stock valued at $1,309,000 after acquiring an additional 2,561 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its stake in Amdocs by 55.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 586 shares of the technology company's stock valued at $50,000 after acquiring an additional 208 shares in the last quarter. 92.02% of the stock is currently owned by hedge funds and other institutional investors.

Amdocs Stock Performance

Shares of DOX traded up $0.47 during mid-day trading on Monday, hitting $88.73. 876,389 shares of the company's stock were exchanged, compared to its average volume of 698,379. Amdocs Limited has a fifty-two week low of $78.61 and a fifty-two week high of $95.41. The firm has a market capitalization of $10.02 billion, a P/E ratio of 18.68, a P/E/G ratio of 1.46 and a beta of 0.52. The business's 50 day moving average is $91.63 and its two-hundred day moving average is $88.34. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 0.21.

Amdocs (NASDAQ:DOX - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The technology company reported $1.78 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.07. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.12 billion. Amdocs had a net margin of 11.39% and a return on equity of 19.52%. The firm's revenue was down 9.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.56 earnings per share. On average, equities analysts expect that Amdocs Limited will post 6.21 earnings per share for the current year.

Amdocs Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Monday, June 30th will be given a $0.527 dividend. The ex-dividend date is Monday, June 30th. This represents a $2.11 dividend on an annualized basis and a yield of 2.38%. Amdocs's payout ratio is currently 44.21%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on DOX. Wolfe Research assumed coverage on shares of Amdocs in a research note on Tuesday, July 8th. They issued an "outperform" rating for the company. Wall Street Zen upgraded shares of Amdocs from a "hold" rating to a "buy" rating in a research note on Saturday, June 7th. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the company has an average rating of "Buy" and an average price target of $105.33.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.